ReviewAdvances in biochemical engineering/biotechnology2026
Robust Production of Cellulases to Develop a Low-Cost Sugar Platform.
Review in Advances in biochemical engineering/biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bioconversion of lignocellulosic biomass into fermentable sugars using cellulase is indispensable for the production of biofuels and chemicals in the biorefining industry. However, the high cost and low efficiency of cellulase pose major obstacles to commercializing this process. In recent years, some significant efforts have been made to facilitate the application of cellulases in industry. Firstly, engineered Trichoderma reesei strains have been developed to enhance extracellular cellulase activities and efficiency. Secondly, the utilization of low-cost inducers and rational control of inducer feeding rates have facilitated economic production of cellulase. Finally, the development of sugar platforms with low cellulase dosage and high sugar concentration has enabled efficient lignocellulose conversion. These systematic efforts have collectively propelled lignocellulose biorefining toward a more economical and efficient industrial future.
Indexed as
Identifiers
42185457What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.